TRIM21 and dermatomyositis: In anti-MDA5+ DM patients, autoreactive B cells produce not only pathogenic anti-MDA5 antibodies but also other autoantibodies, such as anti-RO-52 and anti-SFPQ (splicing factor proline/glutamine-rich) antibodies.